Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Revenue Growth
PODD logo

Insulet Powers Ahead with 30% Revenue Surge to $706M in Q3

PODD10-QFiling Date: 11/7/2025
Insulet Corporation
Description

What this story covers

Insulet Corporation's Q3 2025 10-Q reveals 29.9% revenue growth to $706.3M, driven by Omnipod adoption in the U.S. and international markets. Gross margins improved to 72.2% via efficiencies, while net income rose to $87.6M. Debt reduced significantly, bolstering liquidity at $757M cash. Strategic launches in nine countries and R&D investments fuel expansion, amid tariff and litigation risks.

Story snapshot

CompanyInsulet Corporation
TickerPODD
VariantStandard detailed
Duration10:02
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001145197-25-000069

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in